AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17162709 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (n = 19)
Number of subjects: 46
Study 17162709 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 46
Study 12070631 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic group (intermittent hypoxic exposure for 1 week)
Number of subjects: 14
Study 12070631 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 14
Study 12070631 — intervention group
Group type: COMPARATOR
Intervention: Both groups (hypoxic and control)
Number of subjects: 14
Study 10445623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone exposure (0.2 parts per million)
Number of subjects: 13
Study 10445623 — intervention group
Group type: COMPARATOR
Intervention: Filtered air exposure
Number of subjects: 13
Study 7756073 — intervention group
Group type: EXPERIMENTAL
Intervention: Active compression‐decompression cardiopulmonary resuscitation
Number of subjects: 36
Study 7756073 — intervention group
Group type: COMPARATOR
Intervention: Conventional cardiopulmonary resuscitation
Number of subjects: 36
Study 1964962 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa and Etoposide (total dose: Thiotepa 600-900 mg/M2 over 3 days, Etoposide 1500 mg/M2 over 3 days)
Number of subjects: 10
Study 1964962 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa, Etoposide and BCNU (total dose: BCNU 600 mg/M2 over 4 days)
Number of subjects: 10
Study 504040 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid 250 mg
Number of subjects: 0
Study 504040 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid 650 mg (Control)
Number of subjects: 0
Study 504040 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid
Number of subjects: 0
Study 6393443 — intervention group
Group type: EXPERIMENTAL
Intervention: B-diet plus 3 X 20 g fresh onion per day
Number of subjects: 260
Study 6393443 — intervention group
Group type: EXPERIMENTAL
Intervention: B-diet plus 3 X 200 g green beans per day
Number of subjects: 260
Study 6393443 — intervention group
Group type: COMPARATOR
Intervention: B-diet
Number of subjects: 260
Study 27503325 — intervention group
Group type: EXPERIMENTAL
Intervention: Reloadable wireless bank cards
Number of subjects: 600
Study 27503325 — intervention group
Group type: COMPARATOR
Intervention: Cash payment
Number of subjects: 600
Study 28799964 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB)
Number of subjects: 63
Study 28799964 — intervention group
Group type: COMPARATOR
Intervention: Sham Block (SHAM)
Number of subjects: 63
Study 26638911 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of resveratrol plus 10 mg of piperine
Number of subjects: 16
Study 26638911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 24454949 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour fast (FASTED)
Number of subjects: 15
Study 24454949 — intervention group
Group type: COMPARATOR
Intervention: Normal feeding (FED)
Number of subjects: 15
Study 22045316 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (130 mg)
Number of subjects: 16
Study 22045316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 19096087 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic score based on selected risk factors
Number of subjects: 4142
Study 19096087 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors included: body mass index <18.5 kg/m2 (2 points), diabetes (1 point), congestive heart failure stages III to IV (2 points), peripheral vascular disease stages III to IV (2 points), dysrhythmia (1 point), active malignancy (1 point), severe behavioural disorder (2 points), total dependency for transfers (3 points), unplanned dialysis (2 points)
Number of subjects: 4142
Study 17413118 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavones
Number of subjects: 11
Study 17413118 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone-depleted soy protein
Number of subjects: 11
Study 17413118 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein with enriched isoflavones
Number of subjects: 11
Study 15290200 — intervention group
Group type: EXPERIMENTAL
Intervention: TGDc‐01 tonometer
Number of subjects: 100
Study 15290200 — intervention group
Group type: COMPARATOR
Intervention: Goldmann applanation tonometer
Number of subjects: 100
Study 12170429 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendamustine/prednisolone
Number of subjects: 0
Study 12170429 — intervention group
Group type: COMPARATOR
Intervention: Melphalan/prednisolone
Number of subjects: 0
Study 10094425 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam
Number of subjects: 0
Study 10094425 — intervention group
Group type: COMPARATOR
Intervention: Standard monotherapy (Carbamazepine or Phenytoin)
Number of subjects: 0
Study 7845426 — intervention group
Group type: EXPERIMENTAL
Intervention: Debulking surgery
Number of subjects: 278
Study 7845426 — intervention group
Group type: COMPARATOR
Intervention: No surgery (control)
Number of subjects: 278
Study 2347116 — intervention group
Group type: EXPERIMENTAL
Intervention: Low alcohol beer (reduced weekly alcohol intake from 481 +/- 47 mL to 52 +/- 5 mL)
Number of subjects: 72
Study 2347116 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise programme (three 30 min sessions per week of stationary cycling at 60-70% maximum workload)
Number of subjects: 72
Study 2347116 — intervention group
Group type: COMPARATOR
Intervention: Light exercise programme (pedalling against zero or minimal resistance)
Number of subjects: 72
Study 382878 — intervention group
Group type: EXPERIMENTAL
Intervention: buspirone (N = 18)
Number of subjects: 56
Study 382878 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam (N = 20)
Number of subjects: 56
Study 382878 — intervention group
Group type: COMPARATOR
Intervention: placebo (N = 18)
Number of subjects: 56
Study 31980448 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of azathioprine (AZA) to second anti-TNF therapy
Number of subjects: 90
Study 31980448 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with second anti-TNF (no AZA)
Number of subjects: 90
Study 30431709 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable steroid-releasing implants (mometasone furoate, 370 μg)
Number of subjects: 160
Study 30431709 — intervention group
Group type: COMPARATOR
Intervention: Control (contralateral side without implant)
Number of subjects: 160
Study 30026614 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Cancer-related Insomnia (BBT-CI)
Number of subjects: 71
Study 30026614 — intervention group
Group type: COMPARATOR
Intervention: Healthy Eating Education Learning (HEAL)
Number of subjects: 71
Study 27054583 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 121
Study 27054583 — intervention group
Group type: COMPARATOR
Intervention: Patient education alone
Number of subjects: 121
Study 25015566 — intervention group
Group type: EXPERIMENTAL
Intervention: ePULab (web-based e-learning tool)
Number of subjects: 0
Study 25015566 — intervention group
Group type: COMPARATOR
Intervention: Traditional face-to-face instruction
Number of subjects: 0
Study 21628601 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel active metabolite (pras-AM) exposure
Number of subjects: 1159
Study 20617484 — intervention group
Group type: COMPARATOR
Intervention: Concurrent training (CG, n=8)
Number of subjects: 23
Study 20617484 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (SG, n=8)
Number of subjects: 23
Study 20617484 — intervention group
Group type: COMPARATOR
Intervention: Endurance training (EG, n=7)
Number of subjects: 23
Study 17975981 — intervention group
Group type: EXPERIMENTAL
Intervention: LDI‐100 (1.35 ng of BCG and 2 units of hCG, SC, q 24 h)
Number of subjects: 95
Study 17975981 — intervention group
Group type: COMPARATOR
Intervention: Vinblastine (2 mg/m2, IV, q 1 wk)
Number of subjects: 95
Study 17975981 — intervention group
Group type: EXPERIMENTAL
Intervention: LDI‐100
Number of subjects: 95
Study 15794385 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (IVMP)
Number of subjects: 19
Study 15794385 — intervention group
Group type: COMPARATOR
Intervention: Control (no IVMP)
Number of subjects: 19
Study 12425728 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytosterol-enriched chocolate (1.8 g unesterified phytosterols/d)
Number of subjects: 70
Study 12425728 — intervention group
Group type: COMPARATOR
Intervention: Placebo chocolate
Number of subjects: 70
Study 9928724 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV + ddI + nevirapine
Number of subjects: 68
Study 9928724 — intervention group
Group type: COMPARATOR
Intervention: ZDV + ddI
Number of subjects: 68
Study 7540058 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose magnesium regimen (4.2 +/- 0.7 g magnesium sulfate before bypass, followed by 11.9 +/- 2.8 g magnesium chloride until the first postoperative morning, and 5.5 +/- 1.0 g until the second postoperative morning)
Number of subjects: 81
Study 7540058 — intervention group
Group type: COMPARATOR
Intervention: Low-dose magnesium regimen (2.9 +/- 0.5 g magnesium sulfate at the first postoperative morning, and 1.4 +/- 0.1 g at the second postoperative morning)
Number of subjects: 81
Study 2182736 — intervention group
Group type: EXPERIMENTAL
Intervention: rhEpo (600 U/kg)
Number of subjects: 47
Study 2182736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 6110626 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 0
Study 6110626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31012067 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal noise level and landcover diversity index
Number of subjects: 65
Study 31012067 — intervention group
Group type: EXPERIMENTAL
Intervention: Landcover heterogeneity
Number of subjects: 65
Study 31012067 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise intensity
Number of subjects: 65
Study 29920521 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLL) applied at auriculotherapy points
Number of subjects: 42
Study 29920521 — intervention group
Group type: COMPARATOR
Intervention: Simulation of LLL treatment (control group)
Number of subjects: 42
Study 27431736 — intervention group
Group type: EXPERIMENTAL
Intervention: IB1 topical protective lotion
Number of subjects: 144
Study 24590773 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane (5 years)
Number of subjects: 737
Study 22017519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine 3.5 mg/kg
Number of subjects: 1326
Study 22017519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine 5.25 mg/kg
Number of subjects: 1326
Study 22017519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets (both doses)
Number of subjects: 1326
Study 19886838 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment
Number of subjects: 126
Study 19886838 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 126
Study 19886838 — intervention group
Group type: COMPARATOR
Intervention: IFN-gamma, IL-2, and IL-12 responses
Number of subjects: 126
Study 17261234 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapies based on stratification by disease severity
Number of subjects: 659
Study 17261234 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapies utilized in the trial (specific antibiotics not mentioned)
Number of subjects: 659
Study 15813496 — intervention group
Group type: EXPERIMENTAL
Intervention: Thematically induced arousal through empathy
Number of subjects: 0
Study 11255901 — intervention group
Group type: COMPARATOR
Intervention: Immediate prescription (92 patients)
Number of subjects: 191
Study 11255901 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed prescription (99 patients)
Number of subjects: 191
Study 9734940 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 IU/m2 somatropin per week as daily subcutaneous injections
Number of subjects: 10
Study 9734940 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 10
Study 9734940 — intervention group
Group type: COMPARATOR
Intervention: No treatment (non-consent group)
Number of subjects: 10
Study 7833104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 171
Study 7833104 — intervention group
Group type: COMPARATOR
Intervention: Thiotepa
Number of subjects: 171
Study 3369324 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxification fear group (N = 8)
Number of subjects: 16
Study 3369324 — intervention group
Group type: COMPARATOR
Intervention: Non-fear group (N = 8)
Number of subjects: 16
Study 28926855 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily Fluticasone Furoate/Vilanterole (FF/VI) 200/25 µg via ElliptaTM DPI
Number of subjects: 18
Study 28926855 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily Fluticasone Propionate/Salmeterol (FP/SAL) 500/50 µg via DiskusTM DPI
Number of subjects: 18
Study 26805750 — intervention group
Group type: EXPERIMENTAL
Intervention: CGA-based care (Intervention Group)
Number of subjects: 382
Study 24992553 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg daily
Number of subjects: 321
Study 24992553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321
Study 23033391 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral Domain Optical Coherence Tomography (SD-OCT)
Number of subjects: 186
Study 23033391 — intervention group
Group type: EXPERIMENTAL
Intervention: Time Domain Optical Coherence Tomography (TD-OCT)
Number of subjects: 186
Study 23033391 — intervention group
Group type: EXPERIMENTAL
Intervention: SD-OCT and TD-OCT
Number of subjects: 186
Study 23033391 — intervention group
Group type: EXPERIMENTAL
Intervention: SD-OCT
Number of subjects: 186
Study 23033391 — intervention group
Group type: EXPERIMENTAL
Intervention: TD-OCT
Number of subjects: 186
Study 19895912 — intervention group
Group type: EXPERIMENTAL
Intervention: High calcium milk drink with added vitamin D, magnesium and zinc (HCM)
Number of subjects: 2
Study 17804023 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left PPR
Number of subjects: 15
Study 17804023 — intervention group
Group type: COMPARATOR
Intervention: Cathodal stimulation of left PPR
Number of subjects: 15
Study 17804023 — intervention group
Group type: COMPARATOR
Intervention: Anodal stimulation of the homologous region of the right hemisphere
Number of subjects: 15
Study 17804023 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study 16227798 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition (leaders of 25 networks attended a nine-session program)
Number of subjects: 276
Study 16227798 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 276
Study 12871541 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidote administration (specific antidotes)
Number of subjects: 1877
Study 12871541 — intervention group
Group type: EXPERIMENTAL
Intervention: Major hemorrhage
Number of subjects: 1877
Study 12871541 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K
Number of subjects: 1877
Study 12871541 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamin sulfate
Number of subjects: 1877
Study 12871541 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma
Number of subjects: 1877
Study 12871541 — intervention group
Group type: COMPARATOR
Intervention: Antidote usage comparison
Number of subjects: 1877
Study 12871541 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K administration
Number of subjects: 1877
Study 10692930 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin (2 drops of 0.3% ophthalmic solution every 30 min for 3 h, then every 60 min for the next 3 h)
Number of subjects: 34
Study 10692930 — intervention group
Group type: COMPARATOR
Intervention: Oral ciprofloxacin (single dose of 1000 mg 6 h before surgery)
Number of subjects: 34
Study 8836872 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (31.4 mg/day) plus D-alpha-tocopherol acetate (720 IU/day) supplements
Number of subjects: 7
Study 8354735 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline (mean plasma level 85.3)
Number of subjects: 48
Study 8354735 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in maintenance therapy)
Number of subjects: 48
Study 3524511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin plus tobramycin
Number of subjects: 96
Study 3524511 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin plus tobramycin
Number of subjects: 96
Study 30022578 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation (AHSCT)
Number of subjects: 10
Study 30022578 — intervention group
Group type: COMPARATOR
Intervention: Insulin treatment
Number of subjects: 10
Study 26909786 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) + Total Intravenous Anesthesia (TIVA)
Number of subjects: 23
Study 26909786 — intervention group
Group type: COMPARATOR
Intervention: Total Intravenous Anesthesia (TIVA)
Number of subjects: 23
Study 26909786 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 23
Study 25807408 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle protein fractional synthesis rate measured at 1, 2, 4 weeks, 6, 12, and 24 months after burn injury.
Number of subjects: 87
Study 25807408 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle protein fractional synthesis rate in boys, children older than 3 years, and burns greater than 80% TBSA.
Number of subjects: 87
Study 23631396 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepackaged all‐inclusive kit
Number of subjects: 30
Study 23631396 — intervention group
Group type: COMPARATOR
Intervention: Standard kit
Number of subjects: 30
Study 21055963 — intervention group
Group type: EXPERIMENTAL
Intervention: High COP group (5% albumin in priming, COP maintained above 18 mmHg)
Number of subjects: 70
Study 21055963 — intervention group
Group type: COMPARATOR
Intervention: Standard COP group (0.5 g/kg albumin in priming, COP target at 15 mmHg)
Number of subjects: 70
Study 19776719 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 0
Study 16567158 — intervention group
Group type: EXPERIMENTAL
Intervention: TV group (children watched a 22‐minute cartoon video on TV)
Number of subjects: 24
Study 16567158 — intervention group
Group type: COMPARATOR
Intervention: no TV group (children did not watch TV)
Number of subjects: 24
Study 16567158 — intervention group
Group type: EXPERIMENTAL
Intervention: TV group (children who watched more daily hours of TV)
Number of subjects: 24
Study 16567158 — intervention group
Group type: EXPERIMENTAL
Intervention: TV group (children with a higher frequency of meals eaten in front of the TV at home)
Number of subjects: 24
Study 12627041 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/day for 21 days)
Number of subjects: 40
Study 12627041 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tamoxifen)
Number of subjects: 40
Study 10689253 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of contrast (1.3 mL in 50 mL normal saline initially at 4.0 mL/min)
Number of subjects: 64
Study 10689253 — intervention group
Group type: COMPARATOR
Intervention: Bolus injections of contrast (10 microL/kg each over a period of 30 to 60 seconds)
Number of subjects: 64
Study 7503004 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propafenone 600 mg
Number of subjects: 30
Study 7503004 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 30
Study 2032708 — intervention group
Group type: EXPERIMENTAL
Intervention: Tego 103G biocide soak
Number of subjects: 186
Study 2032708 — intervention group
Group type: COMPARATOR
Intervention: Placebo soak
Number of subjects: 186
Study 2032708 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole therapy
Number of subjects: 186
Study 2032708 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nystan
Number of subjects: 186
Study 2032708 — intervention group
Group type: EXPERIMENTAL
Intervention: General factors
Number of subjects: 186
Study 2032708 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral yeast carriage rate in women
Number of subjects: 186
Study 7086742 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural treatment
Number of subjects: 50
Study 7086742 — intervention group
Group type: COMPARATOR
Intervention: No-treatment (control)
Number of subjects: 50
Study 30427246 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BRJ) 140 mL daily (∼800 mg/d nitrate)
Number of subjects: 10
Study 30427246 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BRJ)
Number of subjects: 10
Study 30427246 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA)
Number of subjects: 10
Study 29178772 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline peroxide (AP)
Number of subjects: 32
Study 29178772 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% sodium hypochlorite (SH)
Number of subjects: 32
Study 29178772 — intervention group
Group type: COMPARATOR
Intervention: Control (C) - distilled water
Number of subjects: 32
Study 25499536 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed protocol by genetic counselors (CP-GC)
Number of subjects: 343
Study 25499536 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed protocol by physicians (CP-MD)
Number of subjects: 343
Study 25499536 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol by genetic counselors (SP-GC)
Number of subjects: 343
Study 23466709 — intervention group
Group type: EXPERIMENTAL
Intervention: S boulardii (1 g/day)
Number of subjects: 165
Study 23466709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 23466709 — intervention group
Group type: EXPERIMENTAL
Intervention: S boulardii
Number of subjects: 165
Study 23466709 — intervention group
Group type: EXPERIMENTAL
Intervention: S boulardii (in nonsmokers)
Number of subjects: 165
Study 21309806 — intervention group
Group type: EXPERIMENTAL
Intervention: ONSI‐56 material lenses
Number of subjects: 28
Study 21309806 — intervention group
Group type: COMPARATOR
Intervention: Boston XO material lenses
Number of subjects: 28
Study 21309806 — intervention group
Group type: EXPERIMENTAL
Intervention: Miraflow cleaner
Number of subjects: 28
Study 21309806 — intervention group
Group type: EXPERIMENTAL
Intervention: Boston Advance cleaner
Number of subjects: 28